These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9174818)

  • 21. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The androgenic effect of 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one in comparison with 17-alpha-methyl-delta-4-androsten-17-beta-ol-3-one].
    Weller O
    Arzneimittelforschung; 1966 Apr; 16(4):465-6. PubMed ID: 6014250
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation, treatment and monitoring of late-onset hypogonadism in males.
    Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC
    Aging Male; 2005 Jun; 8(2):56-8. PubMed ID: 16096159
    [No Abstract]   [Full Text] [Related]  

  • 24. Androgens in men--uses and abuses.
    Bagatell CJ; Bremner WJ
    N Engl J Med; 1996 Mar; 334(11):707-14. PubMed ID: 8594431
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychosocial issues of ART in aging male.
    Carosa E; Volpe R; Martini P; Brandetti F; Di Stasi SM; Lombardo F; Salacone P; Sgrò P; Gandini L; Lenzi A; Jannini EA
    J Endocrinol Invest; 2005; 28(3 Suppl):117-21. PubMed ID: 16042370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen augmentation of epoetin.
    Daniell HW
    J Clin Oncol; 2003 Jun; 21(11):2224; author reply 2224-5. PubMed ID: 12775754
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
    Zitzmann M
    Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer and long-term hormonal treatment of male hypogonadism.
    Medras M; Filus A; Jozkow P; Winowski J; Sicinska-Werner T
    Breast Cancer Res Treat; 2006 Apr; 96(3):263-5. PubMed ID: 16418796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.
    Saad F; Grahl AS; Aversa A; Yassin AA; Kadioglu A; Moncada I; Eardley I
    BJU Int; 2007 May; 99(5):988-92. PubMed ID: 17309554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: treatment of androgen deficiency in the aging male.
    Hernandez A; Baum N
    Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the statues of patients visiting our specialized clinic for hypogonadal men: 5-year experience].
    Kawa G; Taniguchi H; Kinoshita H; Matsuda T
    Hinyokika Kiyo; 2009 Feb; 55(2):87-92. PubMed ID: 19301613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen and bone mass in men.
    Kung AW
    Asian J Androl; 2003 Jun; 5(2):148-54. PubMed ID: 12778327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone improves erectile function in hypogonadal patients with venous leakage.
    Kurbatov D; Kuznetsky J; Traish A
    J Androl; 2008; 29(6):630-7. PubMed ID: 18599885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
    Swerdloff RS; Wang C
    Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male pubertal development and the role of androgen therapy.
    Richmond EJ; Rogol AD
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative characteristics of testosterone preparations for androgen-replacing therapy in male hypogonadism].
    Iudovskiĭ SO; Segal AS; Pushkar' DIu
    Urologiia; 2006; (3):83-4, 86-8. PubMed ID: 16889100
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
    Abrams D
    AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.